A Study of Loco-Regional Liposomal Bupivacaine Injection

• Status: Recruiting
• Trial end date: 2024-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research is to find out if using liposomal bupivacaine solution (bupivacaine liposome) injections during lower extremity revascularization surgery will lower the amount of narcotic drugs used during and following the procedure.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Those who present for elective lower extremity revascularization.

Exclusion Criteria:

• Non-English speaking.

• Chronic pain.

• On opioids greater than 1 weeks.

• Allergy to local anesthetics.

• Use of spinal or epidural for surgery.

• Lack of patient cooperation.

• Lontraindication to regional anesthesia.

• Vulnerable individuals.